Contextualizing biological heterogeneity in brain structural normativity assessments across the aging continuum with the nearest neighbor normativity framework
Authors:
- Ramona LeeningsRLRamona Leenings
- Nils R. WinterNWNils R. Winter
- Jan ErnstingJEJan Ernsting
- Maximilian KonowskiMKMaximilian Konowski
- Vincent HolsteinVHVincent Holstein
- Susanne MeinertSMSusanne Meinert
- Jennifer SpanagelJSJennifer Spanagel
- Carlotta BarkhauCBCarlotta Barkhau
- Lukas FischLFLukas Fisch
- Janik GoltermannJGJanik Goltermann
- Malte F. GerdesMGMalte F. Gerdes
- Dominik GrotegerdDGDominik Grotegerd
Open Access
- 13 November 2026
- journal article
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Abstract
Background: Despite established consensus about the individuality of brain physiology and structural changes, current neuroimaging biomarker paradigms heavily rely on population averages. Here, we define normativity not as a single reference point but as a landscape of permissible configurations arising from diverse physiological manifestations. Methods: We introduce the Nearest Neighbor Normativity (N 3 ) framework, designed to parse the natural heterogeneity in brain structural measurements into a diversity-aware biomarker of brain structural decline. Through repeated comparisons within different demographic subgroups, N 3 contextualizes an individual’s measurements from several viewpoints along the aging continuum. Relying on local density estimation, it accommodates multiple, shared normative configurations within and across age groups. We use T1-weighted MRI data from 29,883 individuals for training and 7,013 individuals for validation, and benchmark our framework against Brain Age models and Normative Modeling. We evaluate each biomarker’s ability to detect neurodegenerative diseases, using them as representative models of atypical brain structural decline. Results: In group-level analyses, the N 3 biomarker shows the largest effect sizes in the detection of Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia. Similarly, the N 3 biomarker achieves the highest predictive performance in the classification of neurodegenerative diseases on a single subject level. Notably, the N 3 estimates remain stable across age and robust to compositional changes in the reference sample. Finally, correlation analyses indicate that it captures distinct and complementary aspects of brain structural variation compared to existing approaches. Conclusions: Our findings underscore that rethinking normativity assessments to explicitly accommodate natural inter-individual variability can advance our collective efforts toward truly personalized patient care.Funding Information
- IMF research instrument of the medical faculty of Mueunster, University of Muenster
- Deutsche Forschungsgemeinschaft (DA1151/11-1)
- Deutsche Forschungsgemeinschaft (CRC 1450—431460824)
- Deutsche Forschungsgemeinschaft (HA7070/3)
This publication has 53 references indexed in Scilit:
- Bringing Imaging Biomarkers Into Clinical Reality in PsychiatryJAMA Psychiatry, 2024
- Genetic and Clinical Correlates of AI-Based Brain Aging Patterns in Cognitively Unimpaired IndividualsJAMA Psychiatry, 2024
- Biomarkers for clinical use in psychiatry: where are we and will we ever get there?World Psychiatry, 2023
- Candidate biomarkers in psychiatric disorders: state of the fieldWorld Psychiatry, 2023
- Framework and baseline examination of the German National Cohort (NAKO)European Journal of Epidemiology, 2022
- MRI-based biomarkers of accelerated aging and dementia risk in midlife: how close are we?Ageing Research Reviews, 2020
- Establishment of Best Practices for Evidence for PredictionJAMA Psychiatry, 2020
- Precision Public Health for the Era of Precision MedicineAmerican Journal of Preventive Medicine, 2016
- The German National Cohort: aims, study design and organizationEuropean Journal of Epidemiology, 2014
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991